Product
tiotropium
2 clinical trials
3 indications
Indication
AsthmaIndication
Pulmonary DiseaseIndication
Chronic ObstructiveClinical trial
A Randomized, Double-blind, Double-dummy, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium Inhalation Capsules 18 mcg Via the HandiHaler® Once Daily to Combivent® Inhalation Aerosol CFC MDI 2 Actuations q.i.d. in COPD Patients Currently Prescribed Combivent® Inhalation Aerosol CFC MDIStatus: , Estimated PCD: 2007-10-08